There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
In the case of WW, analyst Linda Bolton Weiser assigned the stock a buy rating back in March, in a note framed around the question, "Why would an investor be interested in investing in WW, which ...
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and $11 billion for Medicaid over a decade. Total Medicare drug spending over ...
For people taking Ozempic, Wegovy or other GLP-1 medications, Thanksgiving may look a little different. Experts give tips on how to handle challenges and enjoy the holiday.
The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical ...
Strata Decision Technology data finds the number of bariatric surgeries in the Chicago area may have fallen by more than half ...
William Blair's assessment is that MariTide is an improvement on current obesity therapies with a profile that "will be ...
Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue ...
Obesity is associated with increased odds of mood and anxiety disorders, including more serious mental health conditions such as schizophrenia and bipolar disease.
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...
“Patients who take these medications realize that if they follow a healthy diet of more protein and fiber, they are able to ...